Cargando…
The challenge of choosing in cardiovascular risk management
Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. For many years guidelines have listed optimal preventive therapy. More recently, novel therapeutic options have broadened the options for state-of-the-art CV risk management (CVRM). In the majority of patients with C...
Autores principales: | Hoogeveen, R. M., Hanssen, N. M. J., Brouwer, J. R., Mosterd, A., Tack, C. J., Kroon, A. A., de Borst, G. J., ten Berg, J., van Trier, T., van Lennep, J. Roeters, Liem, A., Serné, E., Visseren, F. L. J., Cornel, J. H., Peters, R. J. G., Jukema, J. W., Stroes, E. S. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724475/ https://www.ncbi.nlm.nih.gov/pubmed/34259995 http://dx.doi.org/10.1007/s12471-021-01599-y |
Ejemplares similares
-
Cardiac medication use in patients with suspected ischaemia without obstructive coronary arteries: sex differences and psychological distress
por: Mommersteeg, P. M. C., et al.
Publicado: (2021) -
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome: Practical lessons from a review
por: ten Berg, J. M., et al.
Publicado: (2017) -
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group
por: Damman, P., et al.
Publicado: (2016) -
Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
por: Benschop, Laura, et al.
Publicado: (2019) -
Supraventricular tachycardia and the menstrual cycle
por: Schreuder, M.M., et al.
Publicado: (2019)